Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy ...

Keith Speights has positions in Pfizer and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Merck, Pfizer, and Vertex Pharmaceuticals. The Motley Fool recommends Moderna. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Is there any justification for an investor to favour Vertex over these three companies - which market and sell pharmaceutical products across a range of different indications as opposed to a ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

Here are three reasons to buy Vertex Pharmaceuticals stock like ... This ratio factors in the potential for the company's products awaiting approvals and its late-stage pipeline.

(see more details here) Global biotech company Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is widely recognized for its broad portfolio of products, which includes gene-editing, non-opioid ...

It also makes diagnostics, medical nutrition products, medical devices ... positions in and recommends Abbott Laboratories and Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.

Vertex Pharmaceuticals(NASDAQ ... Novo markets several insulin products, including Fiasp, Levimir, and Tresiba. The company is also researching cell therapies that could someday cure type 1 ...

Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable ...